Ropeginterferon Alfa-2b vs Phlebotomy in Low-Risk Patients With Polycythemia Vera
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Haematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ropeginterferon Alfa-2b Versus Phlebotomy in Low-Risk Patients With Polycythaemia Vera (Low-PV Study): A Multicentre, Randomised Phase 2 Trial
Lancet Haematol 2021 Jan 18;[EPub Ahead of Print], T Barbui, AM Vannucchi, V De Stefano, A Masciulli, A Carobbio, A Ferrari, A Ghirardi, E Rossi, F Ciceri, M Bonifacio, A Iurlo, F Palandri, G Benevolo, F Pane, A Ricco, G Carli, M Caramella, D Rapezzi, C Musolino, S Siragusa, E Rumi, A Patriarca, N Cascavilla, B Mora, E Cacciola, C Mannarelli, GG Loscocco, P Guglielmelli, S Betti, F Lunghi, L Scaffidi, C Bucelli, N Vianelli, M Bellini, MC Finazzi, G Tognoni, A RambaldiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.